Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)
Extreme weakness, fainting, or confusion are also red flags that need immediate attention
Call/Tex us at 503-303-5472 or book online below
Contact The G Law Group Today Our team of skilled mass tort attorneys are well-versed in handling complex failure to warn cases against large pharmaceutical companies
US$ 29.34
US$ 25.78
US$ 29.32
